Suchergebnisse - "Chien, R. N."

1

521 HEPATOCELLULAR CARCINOMA DEVELOPMENT IN HBe-NEGATIVE HEPATITIS B CIRRHOTIC PATIENTS WITH ENTECAVIR TREATMENT

von: Chen, Y.-C.

2013, in: Identification of the antigenic region of

Wird geladen...
2

Hepatic tuberculosis: Comparison of miliary and local form

von: Chien, R. N.

1995, in: Infection

Wird geladen...
3

UGT2B28 Genomic Variation is Associated with Hepatitis B E-Antigen Seroconversion in Response to Entecavir or Peginterferon Therapy

von: Yeh, C.-T.

2016, in: Identification of the antigenic region of

Wird geladen...
4

Increased incidence of HBsAg seroclearance in HBeAg negative chronic hepatitis B patients discontinued Nuc therapy comparing to natural course-a propensity score matched study

von: Jeng, W.-J.

2018, in: Identification of the antigenic region of

Wird geladen...
5

P146 INCREASE OF ACTIVATED REGULATORY T CELLS WAS FOUND ONLY IN IMMUNE CLEARANCE STAGE AND WAS RELATED TO LIVER INFLAMMATION AND GALECTIN-9 IN CHRONIC HEPATITIS B

von: Hu, C.C.

2014, in: Identification of the antigenic region of

Wird geladen...
6

O113 COMBINATION THERAPY WITH PEGINTERFERON ALFA-2a AND A NUCLEOS(T)IDE ANALOGUE FOR HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS: RESULTS OF A LARGE, RANDOMISED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

von: Su, W.-W.

2014, in: Identification of the antigenic region of

Wird geladen...
7

P669 A GENOME-WIDE ASSOCIATION STUDY ON PERSISTENT HBV INFECTION AND ITS CLINICAL SIGNIFICANCE IN MALE HAN-TAIWANESE

von: Chang, S.-W.

2014, in: Identification of the antigenic region of

Wird geladen...
8

Every-two-week ropegienterferon alfa-2b is safe with higher hepatitis B e antigen seroconversion rate in interferon naive patients with chronic hepatitis B infection: A phase 2, open label, randomized, active control, dose finding study

von: Huang, Y.-W.

2018, in: Identification of the antigenic region of

Wird geladen...
9

758 ENTECAVIR PLUS PEGINTERFERON alfa-2a vs. ENTECAVIR ALONE IN THE TREATMENT OF HEPATITIS B e ANTIGEN-POSITIVE CHRONIC HEPATITIS B: AN INTERIM REPORT

von: Liu, C.-J.

2013, in: Identification of the antigenic region of

Wird geladen...
10

P0809 : 98% SVR12 in Korean And Taiwanese patients with chronic genotype 2 HCV infection receiving 12 weeks of sofosbuvir plus ribavirin: Results from an international, multicenter phase 3 study

von: Kao, J.-H.

2015, in: Identification of the antigenic region of

Wird geladen...
11

P0857 : 98% SVR12 in Korean and Taiwanese patients with chronic genotype 1 HCV infection receiving 12 weeks of ledipasvir/sofosbuvir: Results from an international, multicenter phase 3 study

von: Lim, Y.-S.

2015, in: Identification of the antigenic region of

Wird geladen...
12

Ledipasvir/sofosbuvir for 12 weeks is safe and effective in patients with chronic hepatitis C and hepatitis B coinfection: A phase 3 study in Taiwan

von: Liu, C.-J.

2017, in: Identification of the antigenic region of

Wird geladen...
13

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

von: Sarin, S. K.

2015, in: Hepatology international

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!